Phio Pharmaceuticals Corp. Common Stock Fireside chat
Review the key takeaways and the transcript of this earnings call.
- Phio Pharmaceuticals is a company developing immuno-oncology drugs specialized for skin cancer, developing RNA interference (RNAi)-based therapeutics using the INTASYL technology platform.
- In the recent PH-762 Phase 1b trial, safety and efficacy results were positive, showing an 85% response rate across five dose cohorts and 100% pathological cancer clearance in some patients.
- There was no recurrence or disease progression during a 113-day observation period after the clinical trial, and pharmacokinetic data analysis and FDA submission preparations are currently underway.
- The INTASYL technology has a unique mechanism that precisely targets specific genes to help immune cells effectively attack cancer cells.
- CMC processes for commercial-scale drug production were initiated after 12 months of preparation, with rigorous quality control in place to meet FDA requirements.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first five paragraphs, organized by speaker.
안녕하세요, 참석해 주셔서 감사합니다. 약 5분 후에 시작할 예정이니 조금만 기다려 주시기 바랍니다. 안녕하세요, 참석해 주셔서 감사합니다. 안녕하세요, 참석해 주셔서 감사합니다. 약 4분 후에 시작할 예정입니다. 안녕하세요, 하비님. 음소거 상태입니다. 여기 계셨군요. 지금 다시 연결되었습니다.
이제 됐습니다. 네, 안녕하세요, 캘리.
이것만 설정하면 됩니다. 이제 됐습니다. 안녕하세요, 밥.
좋은 아침입니다. 좋은 아침이에요, 밥. 1분 남았으니 거의 오후네요.
네, 거의 다 됐습니다. 1분만 더 기다려 주세요.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
4 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
